Timber Pharmaceuticals files for Chapter 11 in wake of failed merger

seekingalpha2023-11-18

Timber Pharmaceuticals (NYSE:TMBR) reportedly filed for Chapter 11 bankruptcy protection Friday afternoon after shareholders again refused to approve a planned merger with LEO Pharma. The dermatology ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2384539663?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1347295696/image_1347295696.jpg","is_english":true,"pubTime":"2023-11-18 06:44","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2384539663","market":"us","top_or_hot":-1,"title":"Timber Pharmaceuticals files for Chapter 11 in wake of failed merger","media":"seekingalpha","content":"<div>\n<p>Timber Pharmaceuticals (NYSE:TMBR) reportedly filed for Chapter 11 bankruptcy protection Friday afternoon after shareholders again refused to approve a planned merger with LEO Pharma. The dermatology ...</p>\n\n<a href=\"https://seekingalpha.com/news/4038403-timber-pharmaceuticals-files-for-chapter-11-in-wake-of-failed-merger\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Timber Pharmaceuticals files for Chapter 11 in wake of failed merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTimber Pharmaceuticals files for Chapter 11 in wake of failed merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-11-18 06:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4038403-timber-pharmaceuticals-files-for-chapter-11-in-wake-of-failed-merger><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Timber Pharmaceuticals (NYSE:TMBR) reportedly filed for Chapter 11 bankruptcy protection Friday afternoon after shareholders again refused to approve a planned merger with LEO Pharma. The dermatology ...</p>\n\n<a href=\"https://seekingalpha.com/news/4038403-timber-pharmaceuticals-files-for-chapter-11-in-wake-of-failed-merger\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://seekingalpha.com/news/4038403-timber-pharmaceuticals-files-for-chapter-11-in-wake-of-failed-merger","article_id":"2384539663","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1347295696/image_1347295696.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2384539663","pubTimestamp":1700261049,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Timber Pharmaceuticals (NYSE:TMBR) reportedly filed for Chapter 11 bankruptcy protection Friday afternoon after shareholders again refused to approve a planned merger with LEO Pharma. The dermatology ","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药"},"translate_title":"Timber Pharmaceuticals在合并失败后申请破产保护","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMBR":1},"content_text":"Timber Pharmaceuticals (NYSE:TMBR) reportedly filed for Chapter 11 bankruptcy protection Friday afternoon after shareholders again refused to approve a planned merger with LEO Pharma. The dermatology drug developer filed for Chapter 11 protection in a Delaware court, listing its assets as no more than $10M and its liabilities of at least that amount, Bloomberg reported after market close.  Timber disclosed in an SEC filing made early Friday afternoon that the deal failed to win a majority of shareholder votes during a special shareholders meeting. Shares of Timber were trading 17% higher when they were halted for pending news at around 12:40 p.m. ET. Analysts speculated earlier this week that Timber might be forced to declare bankruptcy if shareholders didn’t approve the deal as it didn’t have the cash to pay back the bridge loan LEO had provided ahead of the merger. LEO had offered $14M for Timber, plus a contingency value right worth up to $22M. Payment of the CVR was subject to certain deductions related to 50% repayment of a $3M bridge loan to be provided by LEO. The deal was announced in August but failed to get enough shareholder support at a special meeting held in October.  More on Timber Pharmaceuticals  Timber Pharma slips ahead of shareholder vote on merger Timber Pharmaceuticals announces NYSE acceptance of plan to regain listing compliance Seeking Alpha’s Quant Rating on Timber Pharmaceuticals Historical earnings data for Timber Pharmaceuticals Financial information for Timber Pharmaceuticals","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2384539663"}